- Cyclobenzaprine 5 mg is the usual starting strength because it relieves acute muscle spasm nearly as well as 10 mg with less sedation and dry mouth.
- It is FDA-approved only as a short-term add-on (up to 2 to 3 weeks) to rest and physical therapy for acute musculoskeletal spasm — not for chronic pain, fibromyalgia, or spasticity.
- Any dose or schedule is set by your prescriber; do not self-titrate, and do not confuse 5 mg immediate-release with the 10 mg tablet or the once-daily extended-release capsule (Amrix).
- Drowsiness and dry mouth are common even at 5 mg; the drug is anticholinergic and interacts dangerously with MAOIs and other serotonergic drugs.
- The FDA label and the 2023 AGS Beers Criteria both urge caution in adults 65 and older, where 5 mg is preferred and extended-release is not recommended.
- This is general education, not medical advice — a clinician should confirm cyclobenzaprine is right for you and direct any dose change.
- What Cyclobenzaprine Is and How It Works
- Why 5 Mg Became the Preferred Starting Strength
- Dosing: What Prescribers Typically Order
- Onset and Duration
- Side Effects You Should Expect
- Special Caution in Older Adults
- Drug Interactions and Contraindications
- How Long to Use It
- Frequently Asked Questions
- Is cyclobenzaprine 5 mg strong enough to work?
- Can I take cyclobenzaprine 5 mg with ibuprofen?
- Will cyclobenzaprine 5 mg make me sleepy?
- Can I drink alcohol on cyclobenzaprine 5 mg?
- How is 5 mg different from the 10 mg or extended-release version?
- The Bottom Line
- Sources
PASTE BELOW THIS LINE INTO THE WORDPRESS EDITOR
— (everything below is the HTML body) —
Ask any family physician which muscle relaxant they reach for first, and cyclobenzaprine is almost certainly the answer. The cyclobenzaprine 5 mg tablet has become the preferred starting strength because studies show it relieves acute muscle spasm nearly as well as the 10 mg tablet while causing significantly less drowsiness and dry mouth. Marketed as Flexeril and several generics, cyclobenzaprine is approved for short-term relief of muscle spasm associated with acute painful musculoskeletal conditions — typically neck strain, low back strain, or acute trigger-point pain. Used for 2 to 3 weeks alongside rest, heat, and physical therapy, it can meaningfully shorten the worst days of a flare. This article is general education, not medical advice, and any decision to start or adjust the drug belongs with a prescriber.
What Cyclobenzaprine Is and How It Works
Cyclobenzaprine is structurally almost identical to tricyclic antidepressants like amitriptyline, but its therapeutic effect is on skeletal muscle. Rather than acting on muscle tissue directly, it works in the brain stem to reduce tonic somatic motor activity — essentially, it turns down the nervous system’s tendency to tense protective muscles around an injury. It does not affect neuromuscular transmission or the muscle itself, and it is not an anti-inflammatory or a painkiller in its own right.
According to the FDA prescribing information, cyclobenzaprine is approved only as an adjunct to rest and physical therapy for short-term (up to 2 to 3 weeks) relief of muscle spasm from acute musculoskeletal conditions. It is not approved for cerebral palsy, multiple sclerosis spasticity, or chronic pain, and evidence does not support those uses. For a plain-language overview of what cyclobenzaprine is used for, we cover the indication in more detail separately.
Why 5 Mg Became the Preferred Starting Strength
Before the early 2000s, most patients received 10 mg three times daily. Then a large randomized trial showed the 5 mg dose relieved spasm just as effectively while cutting sedation rates nearly in half. The FDA subsequently approved the 5 mg tablet, and most prescribing references now describe starting there. This is the single biggest reason the 5 mg strength deserves its own discussion: it is not simply “half a pill,” but the dose most guidelines now treat as the sensible default for a first course.
The 5 mg strength is especially suitable for:
- Older adults (cyclobenzaprine appears on the AGS Beers Criteria list of medications to avoid in people 65 and older, but when a clinician judges it necessary, 5 mg is safer than 10 mg)
- Patients who need to work or drive
- People with mild liver impairment
- Anyone taking other sedating medications
Because 5 mg, 10 mg, and the extended-release capsule are genuinely different products, it is worth being clear which one you have. If you want the higher immediate-release strength, see our separate coverage of cyclobenzaprine 10 mg.
Dosing: What Prescribers Typically Order
The FDA-labeled schedule for immediate-release cyclobenzaprine 5 mg is one tablet three times daily for up to 2 to 3 weeks. Some clinicians instead order a single bedtime dose, which minimizes daytime sedation and takes advantage of the drug’s muscle-relaxing effect during sleep. If 5 mg provides inadequate relief, a prescriber may raise the dose — the label describes 7.5 mg or 10 mg three times daily, with a usual maximum of 30 mg per day — but that decision is theirs to make. Do not increase the dose or dosing frequency on your own. Follow the schedule on your label exactly, and raise questions about relief or side effects with the prescriber rather than adjusting the amount yourself. For how clinicians structure these schedules, see our overview of cyclobenzaprine dosing schedules and the practical single-dose safety limits.
An extended-release capsule (Amrix) is available in 15 mg and 30 mg strengths for once-daily dosing. Extended-release is not interchangeable with immediate-release cyclobenzaprine on a milligram-for-milligram basis, and it is a different product from the 5 mg tablet this article covers. Confusing the two is a common medication error, so check the strength and formulation on the bottle.
Onset and Duration
Cyclobenzaprine starts working within about 1 hour of an oral dose, with peak effect at roughly 3 to 8 hours. Its half-life is surprisingly long — around 18 hours on average, and up to about 37 hours in some individuals. That explains why bedtime dosing can cause morning grogginess, why the drug can accumulate over several days, and why once-daily dosing is often enough for a steady effect.
Side Effects You Should Expect
The most common adverse effects of cyclobenzaprine, even at 5 mg, are drowsiness (about 29 to 39 percent), dry mouth (about 21 to 32 percent), and dizziness (roughly 1 to 11 percent). Other side effects include fatigue, headache, nausea, constipation, and blurred vision — an anticholinergic pattern consistent with its tricyclic structure.
Less common but important effects include confusion (especially in older adults), urinary retention, increased intraocular pressure (relevant for narrow-angle glaucoma), and rare cases of arrhythmia. The Mayo Clinic notes that the drug should be used cautiously in patients with heart conduction disturbances, untreated hyperthyroidism, or a recent heart attack.
Special Caution in Older Adults
The FDA label specifically singles out older adults: it advises starting elderly patients at 5 mg and titrating slowly, and warns that the frequency and severity of adverse events — including CNS effects such as hallucinations and confusion, and cardiac events that can lead to falls — are increased in this group. The label states cyclobenzaprine should be used in the elderly “only if clearly needed.” The extended-release capsule is not recommended in older adults at all, because plasma levels and half-life rise substantially with age. The 2023 AGS Beers Criteria reinforce this, listing skeletal muscle relaxants like cyclobenzaprine among drugs to generally avoid in adults 65 and older because they are sedating, anticholinergic, and associated with fracture-causing falls. None of this means the drug can never be used in an older adult — only that the decision, dose, and duration deserve extra care from the prescriber.
Drug Interactions and Contraindications
The most dangerous interaction is with monoamine oxidase inhibitors (MAOIs). Cyclobenzaprine should not be used within 14 days of MAOI therapy because of the risk of hyperpyrexia, seizures, and fatal reactions. Serotonin syndrome has also been reported when cyclobenzaprine is combined with SSRIs, SNRIs, tramadol, meperidine, or MAOIs.
Additional cautions apply with:
- Alcohol (additive sedation)
- Benzodiazepines and opioids (respiratory and CNS depression)
- Other anticholinergic drugs
- Drugs that prolong the QT interval
Cyclobenzaprine is contraindicated during acute recovery after myocardial infarction, in patients with arrhythmias or heart block, and in those with hyperthyroidism. Because the drug interacts with so many common medications, give any prescriber a full medication list before starting it. Our medical conditions guide covers more on the muscle and back-pain conditions where cyclobenzaprine may come up as a treatment option.
How Long to Use It
Cyclobenzaprine is a short-term medication. Research does not support use beyond 2 to 3 weeks, and effectiveness for chronic back pain, fibromyalgia, or neuropathic pain is not established. If muscle spasm is not resolving after 3 weeks, the issue is usually not spasm — it is time to reassess the underlying cause with a clinician rather than to keep taking the drug.
When to seek emergency care: Call 911 if you develop chest pain, irregular heartbeat, severe confusion, high fever with muscle rigidity (a sign of serotonin syndrome), seizure activity, or signs of an allergic reaction such as facial swelling or difficulty breathing.
Frequently Asked Questions
Is cyclobenzaprine 5 mg strong enough to work?
Yes for most acute muscle spasm. The randomized trial that led to FDA approval of the 5 mg tablet found it provided similar relief to 10 mg with fewer side effects. Some patients still need the higher dose, but starting at 5 mg is reasonable for most, and any step up should be a prescriber’s call.
Can I take cyclobenzaprine 5 mg with ibuprofen?
Generally yes, if your clinician approves. Combining cyclobenzaprine with an NSAID like ibuprofen is standard practice for acute musculoskeletal pain — the two work through different mechanisms and the combination is often more effective than either alone. Confirm it is appropriate for you, especially if you have kidney, stomach, or heart concerns.
Will cyclobenzaprine 5 mg make me sleepy?
Usually yes, but less than the 10 mg dose. Expect noticeable drowsiness during the first few days, which often improves with continued use. Take the first few doses when you do not need to drive or perform complex tasks.
Can I drink alcohol on cyclobenzaprine 5 mg?
Avoid or strictly minimize alcohol. The combination amplifies sedation, impairs coordination, and increases the risk of falls. Both substances act on the central nervous system, and the effect is additive.
How is 5 mg different from the 10 mg or extended-release version?
The 5 mg and 10 mg tablets are the same immediate-release drug at different strengths, with 5 mg the usual starting point. Amrix is a once-daily extended-release capsule (15 mg or 30 mg) that is not dose-equivalent to the tablets and is not recommended in older adults. Always check which product and strength you were prescribed.
The Bottom Line
For acute muscle spasm, cyclobenzaprine 5 mg three times daily for up to 2 to 3 weeks provides the best balance of relief and tolerability for most adults. Take it alongside physical therapy, heat, and (if your clinician agrees) an NSAID rather than as a standalone treatment, avoid alcohol and other sedating medications, and let the prescriber direct any change in dose. For related guidance, see our coverage of cyclobenzaprine 10 mg, cyclobenzaprine dosing schedules, and single-dose safety limits.
This article is general education and is not medical advice. Do not start, stop, or change the dose of cyclobenzaprine or any medication on your own. Follow the instructions on your prescription label and talk to a qualified clinician or pharmacist about your situation.
Sources
- FDA prescribing information for cyclobenzaprine (Flexeril) tablets — indications, dosing, elderly use, warnings, and contraindications
- DailyMed (NIH) — current cyclobenzaprine hydrochloride tablet labeling
- Mayo Clinic — cyclobenzaprine (oral route): description, precautions, and side effects
- 2023 American Geriatrics Society (AGS) Beers Criteria — skeletal muscle relaxants among drugs to avoid in older adults
- FDA AMRIX (extended-release cyclobenzaprine) prescribing information — pharmacokinetics and elderly caution
